{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:11:32Z","timestamp":1789143092235,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009918","name":"Oda og Hans Svenningsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007436","name":"Torben og Alice Frimodts Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007436","id-type":"DOI","asserted-by":"publisher"}]},{"name":"A.P. M\u00f8ller Fond"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02262-2","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:46:04Z","timestamp":1768041964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sildenafil provokes headache but not migraine in men with migraine without aura: a randomized, placebo-controlled crossover trial"],"prefix":"10.1186","volume":"27","author":[{"given":"Anas","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5519-9091","authenticated-orcid":false,"given":"Ditte Bork","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1662-3547","authenticated-orcid":false,"given":"Nete Lundager Klokker","family":"Rausgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4210-0523","authenticated-orcid":false,"given":"Christina","family":"Kruuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3336-157X","authenticated-orcid":false,"given":"Dagmar","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-4389","authenticated-orcid":false,"given":"Tore Bjerregaard","family":"Stage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4137-5039","authenticated-orcid":false,"given":"Lanfranco","family":"Pellesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"1","key":"2262_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S1474-4422(16)30293-9","volume":"16","author":"KG Vetvik","year":"2017","unstructured":"Vetvik KG, MacGregor EA (2017) Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol 16(1):76\u201387. https:\/\/doi.org\/10.1016\/S1474-4422(16)30293-9.","journal-title":"Lancet Neurol"},{"key":"2262_CR2","doi-asserted-by":"publisher","unstructured":"Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G, et al (2024) Hallmarks of primary headache: part 1 - migraine. J Headache Pain 31;25(1):189. https:\/\/doi.org\/10.1186\/s10194-024-01889-x.","DOI":"10.1186\/s10194-024-01889-x"},{"key":"2262_CR3","doi-asserted-by":"publisher","unstructured":"Fitzek MP, Boucherie DM, de Vries T, Handtmann C, Fathi H, Raffaelli B, et al (2025) Migraine in men. J Headache Pain 26(1):3. https:\/\/doi.org\/10.1186\/s10194-024-01936-7.","DOI":"10.1186\/s10194-024-01936-7"},{"key":"2262_CR4","doi-asserted-by":"publisher","unstructured":"Sacco S, Porreca F (2024) Breaking barriers in migraine care: Advancing gender medicine to bridge the gap for men. Cephalalgia 44(3):3331024241238157. https:\/\/doi.org\/10.1177\/03331024241238157.","DOI":"10.1177\/03331024241238157"},{"issue":"1","key":"2262_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s10194-024-01796-1","volume":"25","author":"J Olesen","year":"2024","unstructured":"Olesen J (2024) Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives - a narrative review. J Headache Pain 25(1):105. https:\/\/doi.org\/10.1186\/s10194-024-01796-1.","journal-title":"J Headache Pain"},{"issue":"Pt 1","key":"2262_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/brain\/awg009","volume":"126","author":"C Kruuse","year":"2003","unstructured":"Kruuse C, Thomsen LL, Birk S, Olesen J (2003) Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 126(Pt 1):241\u2013247. https:\/\/doi.org\/10.1093\/brain\/awg009.","journal-title":"Brain"},{"issue":"14","key":"2262_CR7","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1177\/0333102419882474","volume":"39","author":"S Younis","year":"2019","unstructured":"Younis S, Christensen CE, Toft NM, S\u00f8borg T, Amin FM, Hougaard A et al (2019) Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil. Cephalalgia 39(14):1776\u20131788. https:\/\/doi.org\/10.1177\/0333102419882474.","journal-title":"Cephalalgia"},{"issue":"6","key":"2262_CR8","doi-asserted-by":"publisher","first-page":"333102424125948","DOI":"10.1177\/03331024241259489","volume":"44","author":"B Raffaelli","year":"2024","unstructured":"Raffaelli B, Do TP, Ashina H, Snellman J, Maio-Twofoot T, Ashina M (2024) Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation. Cephalalgia 44(6):3331024241259489. https:\/\/doi.org\/10.1177\/03331024241259489.","journal-title":"Cephalalgia"},{"key":"2262_CR9","doi-asserted-by":"publisher","unstructured":"Alnajjar M, Iversen DB, Rausgaard NLK, Stage TB, Pellesi L (2024) Migraine-inducing effects of sildenafil in men with migraine without aura: Protocol for a randomized, placebo-controlled crossover trial. Cephalalgia Reports 2024;7. https:\/\/doi.org\/10.1177\/25158163241307329.","DOI":"10.1177\/25158163241307329"},{"key":"2262_CR10","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202.","DOI":"10.1177\/0333102417738202"},{"issue":"10283","key":"2262_CR11","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Terwindt GM, Al-Karagholi MA, de Boer I, Lee MJ, Hay DL et al (2021) Migraine: disease characterisation, biomarkers, and precision medicine. Lancet 397(10283):1496\u20131504. https:\/\/doi.org\/10.1016\/S0140-6736(20)32162-0.","journal-title":"Lancet"},{"issue":"6719","key":"2262_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","volume":"300","author":"JN Matthews","year":"1990","unstructured":"Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300(6719):230\u2013235. https:\/\/doi.org\/10.1136\/bmj.300.6719.230.","journal-title":"BMJ"},{"issue":"1","key":"2262_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s10194-025-02166-1","volume":"26","author":"Q Huang","year":"2025","unstructured":"Huang Q, Li N, Dou H, Han H, Suo M, Wang Y et al (2025) Circulating CGRP as a diagnostic biomarker in female migraine patients: a single-center case-control study. J Headache Pain 26(1):222. https:\/\/doi.org\/10.1186\/s10194-025-02166-1.","journal-title":"J Headache Pain"},{"issue":"1","key":"2262_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s10194-025-02147-4","volume":"26","author":"W Jiang","year":"2025","unstructured":"Jiang W, Yu P, Shi YM, Zhang LX, Cai MT, Yang Y et al (2025) CREB-KIF1A-CGRP-positive feedback loop drives central sensitization in chronic migraine. J Headache Pain 26(1):194. https:\/\/doi.org\/10.1186\/s10194-025-02147-4.","journal-title":"J Headache Pain"},{"issue":"19","key":"2262_CR15","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. N Engl J Med 383(19):1866\u20131876. https:\/\/doi.org\/10.1056\/NEJMra1915327.","journal-title":"N Engl J Med"},{"key":"2262_CR16","doi-asserted-by":"publisher","first-page":"999369","DOI":"10.3389\/fphys.2022.999369","volume":"13","author":"EA Pereira da Silva","year":"2022","unstructured":"Pereira da Silva EA, Mart\u00edn-Arag\u00f3n Baudel M, Navedo MF, Nieves-Cintr\u00f3n M (2022) Ion channel molecular complexes in vascular smooth muscle. Front Physiol 13:999369. https:\/\/doi.org\/10.3389\/fphys.2022.999369.","journal-title":"Front Physiol"},{"issue":"40","key":"2262_CR17","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1523\/JNEUROSCI.0721-22.2022","volume":"42","author":"C Tsantoulas","year":"2022","unstructured":"Tsantoulas C, Ng A, Pinto L, Andreou AP, McNaughton PA (2022) HCN2 ion channels drive pain in rodent models of migraine. J Neurosci 42(40):7513\u20137529. https:\/\/doi.org\/10.1523\/JNEUROSCI.0721-22.2022.","journal-title":"J Neurosci"},{"issue":"8","key":"2262_CR18","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1093\/brain\/awac104","volume":"145","author":"M Watanabe","year":"2022","unstructured":"Watanabe M, Kopruszinski CM, Moutal A, Ikegami D, Khanna R, Chen Y et al (2022) Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine. Brain 145(8):2894\u20132909. https:\/\/doi.org\/10.1093\/brain\/awac104.","journal-title":"Brain"},{"issue":"1","key":"2262_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s10194-025-01966-9","volume":"26","author":"G Krivoshein","year":"2025","unstructured":"Krivoshein G, Rivera-Mancilla E, MaassenVanDenBrink A, Giniatullin R, van den Maagdenberg AMJM (2025) Sex difference in TRPM3 channel functioning in nociceptive and vascular systems: an emerging target for migraine therapy in females? J Headache Pain 26(1):40. https:\/\/doi.org\/10.1186\/s10194-025-01966-9.","journal-title":"J Headache Pain"},{"issue":"6","key":"2262_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/0333102420974362","volume":"41","author":"DS van Casteren","year":"2021","unstructured":"van Casteren DS, Verhagen IE, Onderwater GL, MaassenVanDenBrink A, Terwindt GM (2021) Sex differences in prevalence of migraine trigger factors: A cross-sectional study. Cephalalgia 41(6):643\u2013648. https:\/\/doi.org\/10.1177\/0333102420974362.","journal-title":"Cephalalgia"},{"key":"2262_CR21","doi-asserted-by":"publisher","unstructured":"Chalmer MA, Kogelman LJA, Callesen I, Christensen CG, Techlo TR, M\u00f8ller PL et al (2023) Sex differences in clinical characteristics of migraine and its burden: a population-based study. Eur J Neurol. 2023;30(6):1774\u20131784. https:\/\/doi.org\/10.1111\/ene.15778.","DOI":"10.1111\/ene.15778"},{"issue":"2","key":"2262_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/0333102418786266","volume":"39","author":"AI Scher","year":"2019","unstructured":"Scher AI, Wang SJ, Katsarava Z, Buse DC, Fanning KM, Adams AM et al (2019) Epidemiology of migraine in men: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Cephalalgia 39(2):296\u2013305. https:\/\/doi.org\/10.1177\/0333102418786266.","journal-title":"Cephalalgia"},{"issue":"3","key":"2262_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1515\/sjpain-2022-0152","volume":"23","author":"E Mu\u00f1oz G\u00f3mez","year":"2023","unstructured":"Mu\u00f1oz G\u00f3mez E, Aguilar Rodr\u00edguez M, Serra A\u00f1\u00f3 P, Sempere Rubio N, Moll\u00e0 Casanova S, Ingl\u00e9s M (2023) Sex-related differences in migraine clinical features by frequency of occurrence: a cross-sectional study. Scand J Pain 23(3):553\u2013562. https:\/\/doi.org\/10.1515\/sjpain-2022-0152.","journal-title":"Scand J Pain"},{"issue":"3","key":"2262_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/head.14488","volume":"63","author":"IE Verhagen","year":"2023","unstructured":"Verhagen IE, van der Arend BWH, van Casteren DS, le Cessie S, MaassenVanDenBrink A, Terwindt GM (2023) Sex differences in migraine attack characteristics: A longitudinal E-diary study. Headache 63(3):333\u2013341. https:\/\/doi.org\/10.1111\/head.14488.","journal-title":"Headache"},{"issue":"1","key":"2262_CR25","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s10194-025-02189-8","volume":"26","author":"C Angerh\u00f6fer","year":"2025","unstructured":"Angerh\u00f6fer C, Hoehne CL, Ulrich M, Lange KS, Fitzek MP, Salim Y et al (2025) Sex-related disparities in migraine recognition and management: insights from a tertiary headache center cohort. J Headache Pain 26(1):225. https:\/\/doi.org\/10.1186\/s10194-025-02189-8.","journal-title":"J Headache Pain"},{"issue":"1","key":"2262_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s10194-018-0927-2","volume":"19","author":"CE Christensen","year":"2018","unstructured":"Christensen CE, Younis S, Deen M, Khan S, Ghanizada H, Ashina M (2018) Migraine induction with calcitonin gene-related peptide in patients from erenumab trials. J Headache Pain 19(1):105. https:\/\/doi.org\/10.1186\/s10194-018-0927-2.","journal-title":"J Headache Pain"},{"issue":"6","key":"2262_CR27","doi-asserted-by":"publisher","first-page":"333102424125873","DOI":"10.1177\/03331024241258734","volume":"44","author":"HM Al-Khazali","year":"2024","unstructured":"Al-Khazali HM, Ashina H, Christensen RH, Wiggers A, Rose K, Iljazi A et al (2024) Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab. Cephalalgia 44(6):3331024241258734. https:\/\/doi.org\/10.1177\/03331024241258734.","journal-title":"Cephalalgia"},{"key":"2262_CR28","doi-asserted-by":"publisher","unstructured":"Al-Wakeel S, Sanjikdar H, Al-Tamimi A, Pellesi L (2025) Migraine-inducing effects of cilostazol in men with migraine without aura: protocol for a randomized, placebo-controlled crossover trial. Cephalalgia Reports 2025;8. https:\/\/doi.org\/10.1177\/25158163251388611.","DOI":"10.1177\/25158163251388611"},{"issue":"8","key":"2262_CR29","doi-asserted-by":"publisher","first-page":"e2118543","DOI":"10.1001\/jamanetworkopen.2021.18543","volume":"4","author":"L Pellesi","year":"2021","unstructured":"Pellesi L, Al-Karagholi MA, De Icco R, Coskun H, Elbahi FA, Lopez-Lopez C et al (2021) Effect of vasoactive intestinal polypeptide on development of migraine headaches: A randomized clinical trial. JAMA Netw Open 4(8):e2118543. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.18543.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2262_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10194-025-01959-8","volume":"26","author":"L Pellesi","year":"2025","unstructured":"Pellesi L, Edvinsson L (2025) Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success. J Headache Pain 26(1):22. https:\/\/doi.org\/10.1186\/s10194-025-01959-8.","journal-title":"J Headache Pain"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02262-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02262-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02262-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:05:15Z","timestamp":1768352715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-025-02262-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2262"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02262-2","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DB reported receiving personal fees from Novartis, Pfizer, Lilly, Teva, Lundbeck and Abbvie; receiving travel support from Allergan\/Abbvie, Teva, Pfizer and Lundbeck; and participating in clinical trials supported by Teva, Lundbeck, Novartis, Lilly, and Novo Nordisk Foundation outsidethe submitted work. TBS has given paid lectures for Pfizer and Eisai, he has done consulting for Pfizer, he acted as an expert witness on the behalf of Sandoz A\/S and he collaborated with Novo Nordisk A\/S, all unrelated to the work reported in the present paper. LP serves as member of the Editorial Board of Clinical and Translational Science, The Journal of Headache and Pain, BMC Neurology, Pain Research and Management, European Journal of Medical Research and Brain Conflux. AM, DBI, NLKR and CK declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}